Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 4:30 pm Sale | 2025-04-22 | 13G | Can-Fite BioPharma Ltd. CANF | Orca Capital AG | 157,382,700 4.100% | -217,617,300 (-58.03%) | Filing History |
| 2025-04-16 4:30 pm Purchase | 2025-04-14 | 13G | Can-Fite BioPharma Ltd. CANF | Orca Capital AG | 375,000,000 9.700% | 375,000,000 (New Position) | Filing History |
| 2025-02-14 5:33 pm Sale | 2024-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Armistice Capital, LLC | 440,422 4.990% | -238,108 (-35.09%) | Filing History |
| 2024-11-14 4:48 pm Purchase | 2024-09-30 | 13G | Can-Fite BioPharma Ltd. CANF | Armistice Capital, LLC | 678,530 9.990% | 24,584 (+3.76%) | Filing History |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Armistice Capital, LLC | 653,946 9.990% | 653,946 (New Position) | Filing History |
| 2022-02-14 3:23 pm Unchanged | 2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | CVI Investments, Inc. | 2,316,165 3.700% | 0 (Unchanged) | Filing History |
| 2022-02-11 06:52 am Purchase | 2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Mitchell P. Kopin | 3,949,544 4.990% | 658,379 (+20.00%) | Filing History |
| 2022-02-04 3:59 pm Unchanged | 2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Hudson Bay Capital Management LP | 2,438,415 4.080% | 0 (Unchanged) | Filing History |
| 2021-02-16 09:54 am Sale | 2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | CVI Investments, Inc. | 2,316,165 5.000% | -610,665 (-20.86%) | Filing History |
| 2021-02-08 6:04 pm Purchase | 2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Hudson Bay Capital Management LP | 2,438,415 5.010% | 1,463,415 (+150.09%) | Filing History |
| 2021-01-29 06:51 am Purchase | 2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Mitchell P. Kopin | 3,291,165 6.600% | 3,254,755 (+8939.10%) | Filing History |